Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

The survival of patients with multiple myeloma (MM) has improved substantially since the introduction in the late 1980s of high‐dose chemotherapy (HDT) supported by autologous stem cell transplantation (ASCT). Further improvements have been observed following the availability of immunomodulatory dru...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Internal medicine journal 2015-01, Vol.45 (1), p.94-105
Hauptverfasser:	Quach, H., Joshua, D., Ho, J., Szer, J., Spencer, A., Harrison, S. J., Mollee, P., Roberts, A. W., Horvath, N., Talulikar, D., To, B., Zannettino, A., Brown, R., Catley, L., Augustson, B., Jaksic, W., Gibson, J., Prince, H. M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Advisory Committees Australia - epidemiology Disease-Free Survival Hematopoietic Stem Cell Transplantation - standards Humans multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - epidemiology Practice Guidelines as Topic Societies, Scientific stem cell transplant Survival Rate - trends therapy Transplantation, Autologous Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!